[General characteristics, basis and procedures for high dose chemotherapy procedures supported by hemopoietic stem cell transplantation].
Indications for autologous and allogeneic bone marrow transplantation in hematological malignancies and solid tumours are summarised. AML treatment protocol including induction and consolidation chemotherapy followed by conventional maintenance chemotherapy or high dose chemotherapy with subsequent autologous or allogeneic stem cell transplant are presented. We compared elements and targets of autologous and allogeneic procedures pointing out the major differences regarding transplant related mortality, disease free survival and relapse rates.
Skotnicki
A B
AB
Kliniki Hematologii Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie. alekskot@endo.cm-uj.krakow.pl
Zawirska
D
D
Nowak
W
W
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D016026:Bone Marrow Transplantation / Q000379:methods; D018572:Disease-Free Survival; D006402:Hematologic Diseases / Q000139:chemically induced / Q000517:prevention & control; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009369:Neoplasms / Q000188:drug therapy